Sao Tome and Principe

Sao Tome and Principe

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
7.13 (5.85 - 8.41) 2019 Modelled IHME
7.84 (6.45 - 9.27) 2018 Modelled IHME
8.15 (6.66 - 9.65) 2017 Modelled IHME
8.08 (6.65 - 9.39) 2016 Modelled IHME
8.01 (6.55 - 9.29) 2015 Modelled IHME
8.12 (6.70 - 9.35) 2014 Modelled IHME
8.39 (6.93 - 9.68) 2013 Modelled IHME
8.75 (7.23 - 10.11) 2012 Modelled IHME
9.13 (7.54 - 10.58) 2011 Modelled IHME
9.46 (7.73 - 11.04) 2010 Modelled IHME
9.75 (8.02 - 11.31) 2009 Modelled IHME
10.02 (8.31 - 11.68) 2008 Modelled IHME
10.3 (8.54 - 12.03) 2007 Modelled IHME
10.58 (8.77 - 12.46) 2006 Modelled IHME
10.86 (8.97 - 12.85) 2005 Modelled IHME
11.17 (9.27 - 13.16) 2004 Modelled IHME
11.5 (9.60 - 13.43) 2003 Modelled IHME
11.81 (9.87 - 13.84) 2002 Modelled IHME
12.09 (10.06 - 14.20) 2001 Modelled IHME
12.3 (10.10 - 14.58) 2000 Modelled IHME
12.46 (10.17 - 14.70) 1999 Modelled IHME
12.6 (10.22 - 14.93) 1998 Modelled IHME
12.72 (10.23 - 15.12) 1997 Modelled IHME
12.82 (10.22 - 15.31) 1996 Modelled IHME
12.88 (10.20 - 15.47) 1995 Modelled IHME
12.93 (10.33 - 15.42) 1994 Modelled IHME
12.98 (10.37 - 15.39) 1993 Modelled IHME
13.02 (10.45 - 15.34) 1992 Modelled IHME
13.07 (10.53 - 15.39) 1991 Modelled IHME
13.1 (10.60 - 15.43) 1990 Modelled IHME
3.54 (0.29 - 24.66) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.93 (0.66 - 1.19) 2019 Modelled IHME
1.01 (0.74 - 1.28) 2018 Modelled IHME
1.06 (0.78 - 1.35) 2017 Modelled IHME
1.07 (0.81 - 1.36) 2016 Modelled IHME
1.08 (0.82 - 1.41) 2015 Modelled IHME
1.09 (0.84 - 1.42) 2014 Modelled IHME
1.12 (0.85 - 1.44) 2013 Modelled IHME
1.15 (0.86 - 1.47) 2012 Modelled IHME
1.19 (0.88 - 1.53) 2011 Modelled IHME
1.24 (0.89 - 1.59) 2010 Modelled IHME
1.34 (0.96 - 1.71) 2009 Modelled IHME
1.52 (1.10 - 1.92) 2008 Modelled IHME
1.77 (1.30 - 2.25) 2007 Modelled IHME
2.1 (1.56 - 2.69) 2006 Modelled IHME
2.49 (1.85 - 3.24) 2005 Modelled IHME
3.45 (2.58 - 4.38) 2004 Modelled IHME
5.16 (3.87 - 6.49) 2003 Modelled IHME
7.08 (5.33 - 8.81) 2002 Modelled IHME
8.72 (6.54 - 10.93) 2001 Modelled IHME
9.56 (7.07 - 12.10) 2000 Modelled IHME
9.8 (7.15 - 12.41) 1999 Modelled IHME
9.99 (7.25 - 12.69) 1998 Modelled IHME
10.14 (7.32 - 12.94) 1997 Modelled IHME
10.24 (7.31 - 13.12) 1996 Modelled IHME
10.3 (7.31 - 13.29) 1995 Modelled IHME
10.34 (7.45 - 13.20) 1994 Modelled IHME
10.37 (7.64 - 13.16) 1993 Modelled IHME
10.4 (7.69 - 13.14) 1992 Modelled IHME
10.41 (7.81 - 13.18) 1991 Modelled IHME
10.42 (7.83 - 13.30) 1990 Modelled IHME
1.36 (0.11 - 11.62) 2015 Modelled WHO
Showing out of
Show more

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
49 (41 - 57) 2019 Modelled IHME
49 (41 - 57) 2018 Modelled IHME
49 (41 - 57) 2017 Modelled IHME
49 (41 - 57) 2016 Modelled IHME
49 (41 - 57) 2015 Modelled IHME
49 (41 - 57) 2014 Modelled IHME
49 (41 - 58) 2013 Modelled IHME
49 (41 - 58) 2012 Modelled IHME
49 (41 - 58) 2011 Modelled IHME
50 (41 - 58) 2010 Modelled IHME
49 (41 - 58) 2009 Modelled IHME
49 (41 - 58) 2008 Modelled IHME
49 (41 - 57) 2007 Modelled IHME
49 (41 - 57) 2006 Modelled IHME
48 (40 - 57) 2005 Modelled IHME
49 (41 - 57) 2004 Modelled IHME
49 (41 - 57) 2003 Modelled IHME
49 (41 - 58) 2002 Modelled IHME
49 (41 - 58) 2001 Modelled IHME
49 (41 - 58) 2000 Modelled IHME
49 (41 - 58) 1999 Modelled IHME
49 (41 - 58) 1998 Modelled IHME
49 (41 - 58) 1997 Modelled IHME
49 (40 - 57) 1996 Modelled IHME
49 (40 - 58) 1995 Modelled IHME
49 (40 - 58) 1994 Modelled IHME
49 (40 - 58) 1993 Modelled IHME
49 (40 - 58) 1992 Modelled IHME
49 (41 - 58) 1991 Modelled IHME
49 (41 - 58) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
95 2018 Survey/reported WHO/UNICEF
95 2017 Survey/reported WHO/UNICEF
96 2016 Survey/reported WHO/UNICEF
96 2015 Survey/reported WHO/UNICEF
95 2014 Survey/reported WHO/UNICEF
97 2013 Survey/reported WHO/UNICEF
96 2012 Survey/reported WHO/UNICEF
96 2011 Survey/reported WHO/UNICEF
98 2010 Survey/reported WHO/UNICEF
98 2009 Survey/reported WHO/UNICEF
99 2008 Survey/reported WHO/UNICEF
87 2007 Survey/reported WHO/UNICEF
75 2006 Survey/reported WHO/UNICEF
96 2005 Survey/reported WHO/UNICEF
70 2004 Survey/reported WHO/UNICEF
43 2003 Survey/reported WHO/UNICEF
Showing out of
Show more
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
2018
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
2.4 (1.92 - 3) 2019 Modelled IHME
2.39 (1.92 - 2.99) 2018 Modelled IHME
2.39 (1.92 - 2.99) 2017 Modelled IHME
2.38 (1.92 - 2.97) 2016 Modelled IHME
2.38 (1.91 - 2.98) 2015 Modelled IHME
2.39 (1.92 - 2.99) 2014 Modelled IHME
2.4 (1.93 - 3) 2013 Modelled IHME
2.43 (1.95 - 3.02) 2012 Modelled IHME
2.45 (1.97 - 3.06) 2011 Modelled IHME
2.47 (1.98 - 3.08) 2010 Modelled IHME
2.49 (2 - 3.11) 2009 Modelled IHME
2.52 (2.02 - 3.14) 2008 Modelled IHME
2.54 (2.04 - 3.18) 2007 Modelled IHME
2.57 (2.05 - 3.21) 2006 Modelled IHME
2.59 (2.06 - 3.25) 2005 Modelled IHME
2.62 (2.08 - 3.28) 2004 Modelled IHME
2.64 (2.11 - 3.32) 2003 Modelled IHME
2.67 (2.14 - 3.37) 2002 Modelled IHME
2.69 (2.16 - 3.39) 2001 Modelled IHME
2.71 (2.19 - 3.42) 2000 Modelled IHME
2.73 (2.20 - 3.45) 1999 Modelled IHME
2.75 (2.22 - 3.47) 1998 Modelled IHME
2.76 (2.23 - 3.47) 1997 Modelled IHME
2.78 (2.25 - 3.49) 1996 Modelled IHME
2.79 (2.25 - 3.51) 1995 Modelled IHME
2.8 (2.26 - 3.52) 1994 Modelled IHME
2.81 (2.27 - 3.53) 1993 Modelled IHME
2.82 (2.28 - 3.54) 1992 Modelled IHME
2.83 (2.29 - 3.55) 1991 Modelled IHME
2.84 (2.28 - 3.56) 1990 Modelled IHME
Showing out of
Show more

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
15 (11 - 21) 2019 Modelled IHME
16 (11 - 21) 2018 Modelled IHME
16 (11 - 21) 2017 Modelled IHME
16 (11 - 21) 2016 Modelled IHME
16 (11 - 22) 2015 Modelled IHME
16 (11 - 22) 2014 Modelled IHME
16 (11 - 22) 2013 Modelled IHME
17 (12 - 22) 2012 Modelled IHME
17 (12 - 22) 2011 Modelled IHME
17 (11 - 22) 2010 Modelled IHME
17 (11 - 22) 2009 Modelled IHME
17 (12 - 22) 2008 Modelled IHME
17 (12 - 23) 2007 Modelled IHME
17 (12 - 23) 2006 Modelled IHME
18 (12 - 24) 2005 Modelled IHME
17 (12 - 23) 2004 Modelled IHME
18 (12 - 24) 2003 Modelled IHME
17 (12 - 23) 2002 Modelled IHME
18 (12 - 24) 2001 Modelled IHME
18 (12 - 24) 2000 Modelled IHME
18 (12 - 24) 1999 Modelled IHME
18 (12 - 24) 1998 Modelled IHME
18 (12 - 24) 1997 Modelled IHME
18 (12 - 24) 1996 Modelled IHME
18 (13 - 25) 1995 Modelled IHME
18 (12 - 25) 1994 Modelled IHME
18 (12 - 25) 1993 Modelled IHME
18 (12 - 25) 1992 Modelled IHME
18 (12 - 25) 1991 Modelled IHME
18 (12 - 25) 1990 Modelled IHME
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
2018
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
7.13 (%)
2019
(5.85 - 8.41(%))
IHME
HCV (RNA/cAg+)
2.4 (%)
2019
(1.92 - 3(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
23
2019
(16 - 32)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
4
2019
(2 - 5)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.93 (%)
2019, latest modelled
(0.66 - 1.19(%))
IHME

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines